William Plunkett

Years Active: 2015-2022
Publications (10 Years): 5

The University of Texas M.D. Anderson Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Texas M.D. Anderson Cancer Center

United States

Professor :: Department of Experimental Therpautics

Publications

Rong Chen, Yuling Chen, Ping Xiong, Daniella Zheleva, David Blake, Michael J Keating, William G Wierda, William Plunkett
Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells. Leukemia 36 (6) (2022)
Xiaojun Liu, Yingjun Jiang, Billie Nowak, Satoshi Ichikawa, Masaki Ohtawa, Akira Matsuda, William Plunkett
Repair of DNA damage induced by the novel nucleoside analogue CNDAG through homologous recombination. Cancer chemotherapy and pharmacology 85 (4) (2020)
Priyanka Banerjee, Ronghua Zhang, Cristina Ivan, Giovanni Galletti, Karen Clise-Dwyer, Federica Barbaglio, Lydia Scarfò, Miguel Aracil, Christiane Neumann, William Wierda, William Plunkett, Federico Caligaris-Cappio, Varsha Gandhi, Michael J Keating, Maria Teresa S Bertilaccio
Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia. Cancer immunology research 7 (12) (2019)
Xiaojun Liu, Yingjun Jiang, Kei-Ichi Takata, Billie Nowak, Chaomei Liu, Richard D Wood, Walter N Hittelman, William Plunkett
CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death. Molecular cancer therapeutics 18 (12) (2019)
William Plunkett
Arginine addiction in AML. Blood 125 (26) (2015)

William Plunkett.css-eqlu8i{font-size:small;padding-left:4px;}